Skip to main content
Abstract
Originally Published 30 January 2025
Free Access

Abstract WP268: The COVID-19 Pandemic Significantly Affected Acute Ischemic Stroke Subtype, Patient Characteristics, and Outcomes

Abstract

Introduction: The overall composition of stroke subtype is typically stable within biogeographical groups. Whether the COVID-19 pandemic impacted stroke etiology is still being investigated, but most studies have been performed outside the United States. This study sought to determine the composition of acute ischemic strokes (AIS) before and during the pandemic.
Methods: This retrospective cohort study was conducted at a comprehensive stroke center in Colorado (USA). Adults (≥18) with AIS were compared based on admission date: Pre-COVID period (1/1/2019 – 12/31/2019) vs. COVID period (3/1/2020 – 3/1/2021). Stroke subtype was examined using TOAST classification: 1) large artery atherosclerosis; 2) cardioembolic; 3) small vessel occlusion; 4) other known etiology (e.g., hematologic disorders or arterial dissection); 5) cryptogenic stroke. Comparisons were made with Pearson chi-square tests.
Results: There were 2,130 patients with AIS during the study period: Pre-COVID (n=1,034) and COVID (n=1,096). There were significant differences in stroke subtype by time period (Table 1). Compared to the pre-COVID period, the COVID period had a lower proportion of strokes from large artery atherosclerosis (17.6% vs. 12.1%, p<0.001) and small vessel occlusion (10.1% vs. 7.7%, p=0.05), and significantly more cryptogenic strokes (25.6% vs. 31.8%, p=0.002); rates of cardioembolic stroke and other known etiology were similar between time periods. There were no differences in age, race, and most comorbidities by time period. Compared to the pre-COVID period, there were fewer males (56.1% vs. 49.0%, p=0.001) and more patients with atrial fibrillation (17.2% vs. 21.2%, p=0.02) during the COVID period. Stroke severity and outcomes also differed between time periods. Patients admitted during the COVID period were more likely to be endovascularly treated (17.8% vs. 22.2%, p=0.01), to have more severe strokes (NIHSS ≥21, 9.8% vs. 12.7%, p=0.01), and to have worse discharge mRS compared to patients admitted pre-COVID (Table 1).
Conclusion: In the setting of a widespread pandemic such as COVID-19, stroke etiology, demographics, and clinical outcomes can shift dramatically. These changes included a higher rate of cryptogenic strokes, fewer strokes from large artery atherosclerosis and small vessel occlusion, more strokes among females, a higher number of patients with atrial fibrillation, more patients requiring endovascular treatment, more severe strokes, and worse clinical outcomes.

eLetters(0)

eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.

Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.

Information & Authors

Information

Published In

History

Published online: 30 January 2025
Published in print: February 2025

Permissions

Request permissions for this article.

Keywords

  1. Post-COVID
  2. Ischemic stroke
  3. Epidemiology
  4. Endovascular Therapy
  5. Infectious Diseases

Authors

Affiliations

Anna Belits, MD
Swedish Medical Center, Englewood, Colorado, United States
Yasaman Pirahanchi, MD
Universtiy of California, San Diego, Englewood, Colorado, United States
Frank Wang, MD
Swedish Medical Center, Englewood, Colorado, United States
Katie Higgins, MD
Swedish Medical Center, Englewood, Colorado, United States
Diana Kim, MD
Swedish Medical Center, Englewood, Colorado, United States
Ian Rankine, MD
Swedish Medical Center, Englewood, Colorado, United States
Kristin Salottolo, MPH
Swedish Medical Center, Englewood, Colorado, United States
David Bar-Or, MD
Swedish Medical Center, Englewood, Colorado, United States
Christian Burrell, MD
Blue Sky Neurology, Englewood, Colorado, United States

Notes

For author disclosure information, please visit the AHA International Stroke Conference website.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

View Options

View options

PDF and All Supplements

Download PDF and All Supplements
Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to access the full text.

Purchase access to this article for 24 hours

Abstract WP268: The COVID-19 Pandemic Significantly Affected Acute Ischemic Stroke Subtype, Patient Characteristics, and Outcomes
Stroke
  • Vol. 56
  • No. Suppl_1

Purchase access to this journal for 24 hours

Stroke
  • Vol. 56
  • No. Suppl_1
Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

Figures

Tables

Media

Share

Share

Share article link

Share

Comment Response